Need Help? Call 1­-866-­796-­7386
« back to stock screener

  VRX stock: Valeant Pharmaceuticals Intl I

Current Rating
Strong Buy

Previous Rating:

Hold/Sell
Our Stock Ratings
double the S&P500!
Learn more.
Company Statistics
Price
$10.86
Market Cap
4.66B
Sector
Health Care
Div. Growth
-
P/E
-
P/B
1.53
P/S
0.5
Dividend %
-
P/CF
-
P/FCF
2.7
Op. Cash Flow
2.09M
FCF
5.1
Op. Margin
-5.90%
Net Margin
-24.90%
ROE
-52.70%
ROI
-1.60%
ROA
-5.20%
EPS Growth
-
Current Ratio
1.4
Debt/Equity
946.90%
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Wound Management Technologies (WNDM) $0.08 - - 8.1M Strong Buy
Momenta Pharmaceuticals, Inc. (MNTA) $13.40 - - 1.09B Strong Buy
Merus Labs International Inc ( (MSLI) $0.89 - - 108.3M Strong Buy
Lannett Company, Inc. (LCI) $21.20 - - 812.6M Strong Buy
Kindred Healthcare, Inc. (KND) $8.10 - 5.30% 753.7M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More